• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Index insights
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Coronavirus
  • More reports can be found here

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Topics » Briefs » In the clinic

In the clinic
In the clinic RSS Feed RSS

In the clinic for July 8, 2025

July 8, 2025
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Angle.
Read More

In the clinic for July 8, 2025

July 8, 2025
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Agenus, Apogee, Beyondspring, Blue Lake, Cogent, Cyanvac, Immix, Jasper, Yiviva.
Read More

In the clinic for July 8, 2025

July 8, 2025
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Bio-Thera, Chemomab, Everest Medicines.
Read More

In the clinic for July 7, 2025

July 7, 2025
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Bioatla, Everest, Inventiva, Marengo, Novartis.
Read More

In the clinic for July 3, 2025

July 3, 2025
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Seekin.
Read More

In the clinic for July 3, 2025

July 3, 2025
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Bio-Thera, Cue, Genenta, Ferring, Organon, Pneumagen, Vyne.
Read More

In the clinic for July 2, 2025

July 2, 2025
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Sphingotec.
Read More

In the clinic for July 2, 2025

July 2, 2025
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alligator, Arcturus, Atai, Beckley, Cytodyn, I-Mab, Mineralys, Sensorion, Verastem.
Read More

In the clinic for July 1, 2025

July 1, 2025
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Cognito, Elutia, Implantica, Novocure, Stereotaxis.
Read More

In the clinic for July 1, 2025

July 1, 2025
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alto, AN2, Argenx, Artelo, Ashvattha, Aurinia, Biogen, Celcuity, Chemomab, Corbus, Hansa, Idorsia, Inmune, InvIos, Moderna, OS.
Read More
Previous 1 2 3 4 5 6 7 8 9 … 287 288 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 8, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for July 8, 2025.
  • Illustration of the β2-adrenergic receptor

    Exercise-mimicking compound offers alternative to GLP-1 therapies

    BioWorld
    An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 8, 2025
  • Kidney disease illustration

    Prokidney produces positive phase II CKD data, thunderous stock surge

    BioWorld
    A mixed bag of top-line phase II data prompted stellar stock results for Prokidney Corp. and its chronic kidney disease (CKD) and diabetes therapy, rilparencel....
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe